Skip to main content
SpringerLink
Log in

Anemia Management

  • Chapter
  • First Online:
Pediatric Dialysis Case Studies

Abstract

Anemia is a frequent complication of chronic kidney disease, most commonly the result of decreased production of erythropoietin and/or decreased iron availability. A variety of factors result in hyporesponsiveness to therapy with an erythropoietic-stimulating agent (ESA), including increased levels of hepcidin that rise in the setting of inflammation. Finally, copper deficiency is an uncommon cause of ESA resistance, and the associated anemia can result from an excessive intake of zinc and an associated enhanced fecal loss of copper.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fadrowski JJ, Pierce CB, Cole SR, Moxey-Mims M, Warady BA, Furth SL. Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. Clin J Am Soc Nephrol CJASN. 2008;3(2):457–62. PubMed PMID: 18235140. Pubmed Central PMCID: PMC2390950. Epub 2008/02/01. eng

    Article  CAS  PubMed  Google Scholar 

  2. Atkinson MA, Martz K, Warady BA, Neu AM. Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS. Pediatr Nephrol (Berlin, Germany). 2010;25(9):1699–706. PubMed PMID: 20464428. Epub 2010/05/14. eng

    Article  Google Scholar 

  3. Warady BA, Silverstein DM. Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease. Pediatr Nephrol (Berlin, Germany). 2014;29(9):1493–505. PubMed PMID: 24005791

    Article  Google Scholar 

  4. Kuriyama R, Kogure H, Itoh S, Kikuchi K, Ichikawa N, Nomura Y, et al. Angiotensin converting enzyme inhibitor induced anemia in a kidney transplant recipient. Transplant Proc. 1996;28(3):1635. PubMed PMID: 8658817. Epub 1996/06/01. eng

    CAS  PubMed  Google Scholar 

  5. Warady BA, Arar MY, Lerner G, Nakanishi AM, Stehman-Breen C. Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease. Pediatr Nephrol (Berlin, Germany). 2006;21(8):1144–52. PubMed PMID: 16724235. Epub 2006/05/26. eng

    Article  Google Scholar 

  6. Schaefer F, Hoppe B, Jungraithmayr T, Klaus G, Pape L, Farouk M, et al. Safety and usage of darbepoetin alfa in children with chronic kidney disease: prospective registry study. Pediatr Nephrol (Berlin, Germany). 2015;31(3):443–53. PubMed PMID: 26482252. Epub 2015/10/21. Eng

    Article  Google Scholar 

  7. KDIGO. Clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2012;2(Suppl August):270–335.

    Google Scholar 

  8. Koury MJ, Haase VH. Anaemia in kidney disease: harnessing hypoxia responses for therapy. Nat Rev Nephrol. 2015;11(7):394–410.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Nangaku M, Eckardt KU. Hypoxia and the HIF system in kidney disease. J Mol Med (Berlin, Germany). 2007;85(12):1325–30. PubMed PMID: 18026918. Epub 2007/11/21. eng

    Article  Google Scholar 

  10. Falke LL, Gholizadeh S, Goldschmeding R, Kok RJ, Nguyen TQ. Diverse origins of the myofibroblast-implications for kidney fibrosis. Nat Rev Nephrol. 2015;11(4):233–44. PubMed PMID: 25584804. Epub 2015/01/15. eng

    Article  CAS  PubMed  Google Scholar 

  11. Sargent JA, Acchiardo SR. Iron requirements in hemodialysis. Blood Purif. 2004;22(1):112–23. PubMed PMID: 14732819. Epub 2004/01/21. eng

    Article  CAS  PubMed  Google Scholar 

  12. Kalantar-Zadeh K, Streja E, Miller JE, Nissenson AR. Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia? Adv Chronic Kidney Dis. 2009;16(2):143–51. PubMed PMID: 19233073. Epub 2009/02/24. eng

    Article  PubMed  Google Scholar 

  13. Besarab A, Coyne DW. Iron supplementation to treat anemia in patients with chronic kidney disease. Nat Rev Nephrol. 2010;6(12):699–710. PubMed PMID: 20956992. Epub 2010/10/20. eng

    Article  CAS  PubMed  Google Scholar 

  14. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102(3):783–8. PubMed PMID: 12663437. Epub 2003/03/29. eng

    Article  CAS  PubMed  Google Scholar 

  15. Atkinson MA, Kim JY, Roy CN, Warady BA, White CT, Furth SL. Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort. Pediatr Nephrol (Berlin, Germany). 2015;30(4):635–43. PubMed PMID: 25380788. Pubmed Central PMCID: PMC4336204. Epub 2014/11/09. eng

    Article  Google Scholar 

  16. Zaritsky J, Young B, Gales B, Wang HJ, Rastogi A, Westerman M, et al. Reduction of serum hepcidin by hemodialysis in pediatric and adult patients. Clin J Am Soc Nephrol CJASN. 2010;5(6):1010–4. PubMed PMID: 20299375. Pubmed Central PMCID: PMC2879302. Epub 2010/03/20. eng

    Article  PubMed  Google Scholar 

  17. Fried W. The liver as a source of extrarenal erythropoietin production. Blood. 1972;40(5):671–7. PubMed PMID: 4637502. Epub 1972/11/01. eng

    CAS  PubMed  Google Scholar 

  18. Bamgbola O. Resistance to erythropoietin-stimulating agents: etiology, evaluation, and therapeutic considerations. Pediatr Nephrol (Berlin, Germany). 2012;27(2):195–205. PubMed PMID: 21424525. Epub 2011/03/23. eng

    Article  Google Scholar 

  19. Borzych-Duzalka D, Bilginer Y, Ha IS, Bak M, Rees L, Cano F, et al. Management of anemia in children receiving chronic peritoneal dialysis. J Am Soc Nephrol JASN. 2013;24(4):665–76. PubMed PMID: 23471197. Pubmed Central PMCID: 3609132

    Article  PubMed  Google Scholar 

  20. Higuchi T, Matsukawa Y, Okada K, Oikawa O, Yamazaki T, Ohnishi Y, et al. Correction of copper deficiency improves erythropoietin unresponsiveness in hemodialysis patients with anemia. Intern Med (Tokyo, Japan). 2006;45(5):271–3. PubMed PMID: 16595992. Epub 2006/04/06. eng

    Article  Google Scholar 

  21. Swaminathan S. Trace elements, toxic metals, and metalloids in kidney disease. In: J.D. Kopple, S.G. Massry, Kalantar-Zadeh K, editors. Nutritional management of renal disease. 3rd. San Diego: Elsevier Inc.; 2013. p. 339–349.

    Google Scholar 

  22. Duncan A, Yacoubian C, Watson N, Morrison I. The risk of copper deficiency in patients prescribed zinc supplements. J Clin Pathol. 2015;68(9):723–5. PubMed PMID: 26085547. Epub 2015/06/19. Eng

    Article  CAS  PubMed  Google Scholar 

  23. Richards MP, Cousins RJ. Mammalian zinc homeostasis: requirement for RNA and metallothionein synthesis. Biochem Biophys Res Commun. 1975;64(4):1215–23. PubMed PMID: 1137597. Epub 1975/06/16. eng

    Article  CAS  PubMed  Google Scholar 

  24. Hein MS. Copper deficiency anemia and nephrosis in zinc-toxicity: a case report. S D J Med. 2003;56(4):143–7. PubMed PMID: 12728841. Epub 2003/05/06. Eng

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Nephrology, University of Missouri, Kansas City School of Medicine Children’s Mercy Hospital, Kansas City, MO, USA

    Bradley A. Warady

Authors
  1. Bradley A. Warady
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bradley A. Warady .

Editor information

Editors and Affiliations

  1. Division of Pediatric Nephrology, University of Missouri, Kansas City School of Medicine, Children’s Mercy Hospital, Kansas City, Missouri, USA

    Bradley A Warady

  2. Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany

    Franz Schaefer

  3. Division of Pediatric Nephrology, Department of Pediatrics, Stanford University School of Medicine, Lucile Packard Children’s Hospital Stanford, Stanford, California, USA

    Steven R. Alexander

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Warady, B.A. (2017). Anemia Management. In: Warady, B., Schaefer, F., Alexander, S. (eds) Pediatric Dialysis Case Studies. Springer, Cham. https://doi.org/10.1007/978-3-319-55147-0_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-55147-0_23

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-55145-6

  • Online ISBN: 978-3-319-55147-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation